三七通舒胶囊治疗常见耳源性眩晕的多中心随机对照临床研究

孟娟; 刘波; 李晓媛; 杨玉成; 刘世喜; 孔维佳; 胡国华

doi:10.13201/j.issn.1001-1781.2012.07.001

三七通舒胶囊治疗常见耳源性眩晕的多中心随机对照临床研究

- 1 四川大学华西医院耳鼻咽喉头颈外科(成都, 610041);
- 2 华中科技大学同济医学院附属协和医院耳鼻咽喉科;
- 3 重庆医科大学附属第一医院耳鼻咽喉头颈外科
基金项目:
国家科技部十一五科技支撑计划(No:2007BAI18B13)

详细信息

通讯作者: 刘世喜,E-mail:liusx999@163.com

中图分类号: R441.2

收稿日期: 2011-01-06

Clinical effectiveness and safety of Sanchi Tong Shu capsule in the treatment of aural vertigo:a multi-center randomized controlled clinical trial

- 1 Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China;
- 2 Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology;
- 3 Department of Otolaryngology Head and Neck Surgery, First Affiliated Hospital, Chongqing University of Medical Science

More Information

Corresponding author: LIU Shixi, E-mail: liusx999@163.com

Received Date: 06 January 2011

摘要

摘要: 目的:探讨三七通舒胶囊治疗常见耳源性眩晕疾病的疗效及安全性。方法:采用多中心随机对照试验方法,将206例常见耳源性眩晕(突发性聋伴眩晕、梅尼埃病和良性阵发性位置性眩晕)患者随机分为三七通舒组(155例)和敏使朗组(51例),治疗期为14 d。治疗前后使用眩晕障碍量表(DHI)进行生活质量评估。结果:采用全分析集(FAS)分析三七通舒组和敏使朗组有效率,结果分别为84.86%和90.92%(P>0.05);采用符合方案集(PPS)分析的结果分别为84.76%和90.92%(P>0.05)。治疗14 d后,FAS和PPS分析表明:2组DHI评分均较治疗前降低,且各分项(包括身体、情绪、功能)的评分也较治疗前降低,差异有统计学意义(P<0.01);2组间治疗前后DHI评分的差值,以及各分项(包括身体、情绪、功能)评分的差值,差异均无统计学意义(均P>0.05)。安全性分析表明:三七通舒组不良反应发生率为3.29%,敏使朗组为7.84%,2组间比较差异无统计学意义(P>0.05)。结论:三七通舒胶囊是一种安全、有效的治疗常见耳源性眩晕疾病的药物。
- 眩晕 /
- 三七通舒胶囊 /
- 敏使朗 /
- 随机对照试验
Abstract: Objective: To evaluate the clinical effectiveness and safety of Sanchi Tong Shu capsule in the treatment of common aural vertigo.Method: A multi-center randomized controlled trial was designed to study 206 vertigo patients who were randomly allocated into one of the two groups. One group was treated with Sanchi Tong Shu capsule for 14 days,another group was treated with betahistine mesilate tablets for 14 days.Result: The clinical effectiveness rates of the two groups were 84.86% and 90.92% respectively according to FAS analysis and 84.76%, 90.92% respectively according to PPS analysis. No statistic significance difference was found between the two groups(P>0.05). After 14 days treatment, total DHI and all the subsection(including body,emotion and fuction) scores of the two groups were all decreased compared with treatment before(P<0.01). Compared the difference value of the total DHI and subsection scores before and after treatment, the two groups have no difference(P>0.05). The adverse effective rate of the two groups were 3.29% and 7.84% respectively and there was no statistic difference between the two groups(P>0.05).Conclusion: Sanchi Tong Shu capsule is a safe and effective drug for the treatment of common aural vertigo.
- vertigo /
- sanchi tong shu capsule /
- betahistine mesilate tablets /
- randomized controlled trial

HTML全文

参考文献(16)

[1]	孔维佳, 刘波, 冷样名. 眩晕疾病的个体化综合治疗[J]. 临床耳鼻咽喉头颈外科杂志,2008,22(4):145-150.
[2]	周东,洪震,王拥军,等.三七通舒胶囊治疗缺血性脑卒中的多中心临床研究[J]. 中国中药杂志,2008,33(22):2692-2696.
[3]	徐皓亮,刘宛斌,饶曼人.三七皂苷Rg1对实验性血栓形成的影响及其机制探讨[J].药学学报,1997,32(7):502-505.
[4]	侯安会.三七的临床运用和实验研究概要[J].中医药信息,1999,16(6):21-24.
[5]	中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2005, 41(8):569-569.
[6]	中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉科学分会.梅尼埃病的诊断依据和疗效评估(2006年, 贵阳)[J].中华耳鼻咽喉头颈外科杂志,2007,42(3):163-163.
[7]	中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉科学分会.良性阵发性位置性眩晕的诊断依据和疗效评估(2006年,贵阳)[J].中华耳鼻咽喉头颈外科杂志,2007,42(3):163-164.
[8]	JACOBSON G P, NEWMAN C W. The development of the Dizziness Handicap Inventory [J].Arch Otolaryngol Head Neck Surg, 1990,116:424-427.
[9]	SHAIA W T, ZAPPIA J J, BOJRAB D I,et al. Success of posterior semicircular canal occlusion and application of the dizziness handicap inventory[J].Otolaryngol Head Neck Surg,2006,134:424-430.
[10]	NEUHAUSER H K,VON BREVERN M,RADTKE A,et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population [J].Neurology,2005,65:898-904.
[11]	黄选兆,汪吉宝.实用耳鼻咽喉头颈外科学[M].北京:人民卫生出版社,2004:1011-1012.
[12]	张微微,周小英.三七通舒胶囊对大鼠局灶脑缺血再灌注后神经功能保护作用[J].中国临床康复,2005,9(41):99-101.
[13]	陈雪平,徐严明,罗祖明. 三七通舒胶囊在体外模拟脑缺血再灌注诱导的神经元损伤中的保护作用[J].华西医学,2008,23(4):808-810.
[14]	李经华,赵广利.三七通舒胶囊治疗颈动脉粥样硬化斑块30例临床观察[J].甘肃中医,2009,22(2):31-32.
[15]	DZIADZIOLA J K, LAURIKAINEN E L, RACHEL J D,et al.Betahistine increases vestibular blood flow[J].Otolaryngol Head Neck Surg, 1999,120: 400-405.
[16]	TIGHILET B,LEONARD J,LACOUR M. Betahistine dihydrochloride treatment facilitates vestibula compensation in the cat[J].J Vestib Res,1995,5:53-66.